
In this episode, Bernie and Anthony team up with lymphoma experts Dr. Jon Weiss, Dr. James Davis, Dr. Eugene Przespolewski, and Dr. Aaron "Papa Heme" Goodman to discuss the latest updates in the front-line treatment of...


Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks!Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
22%
Guest openness
Selective
Sign up to generate a grounded pitch for WolverHeme Happy Hour.
Signup to Generate a PitchWelcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks!
Recent episodes include "Episode 49.5: R-CHOP and Chill - the Coolest Therapies at the Front of our Minds" (9 October 2026, 58 minutes), "VAR Review with Dr. Bixby: Reversing the Call on MPAL" (1 July 2026, 67 minutes), and "Bispecifics ate CAR-T's lunch: a multiple myeloma debate" (11 June 2026, 56 minutes).
WolverHeme Happy Hour publishes roughly monthly, with episodes averaging 58 minutes across 51 episodes.
Booking probability for WolverHeme Happy Hour is 22%, and the host is rated Selective on guests. WolverHeme Happy Hour requires a Pod Score of 80 or higher. WolverHeme Happy Hour's contact route on record: verified email.
The strongest fits for WolverHeme Happy Hour are Doctors & Physicians. WolverHeme Happy Hour has a health audience.
WolverHeme Happy Hour is a health podcast with 51 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

In this episode, Bernie and Anthony team up with lymphoma experts Dr. Jon Weiss, Dr. James Davis, Dr. Eugene Przespolewski, and Dr. Aaron "Papa Heme" Goodman to discuss the latest updates in the front-line treatment of...

In this episode, Anthony and Bernie are joined by the great Dr. Bixby to discuss the difficulties in the diagnosis and treatment of acute leukemias of mixed or ambiguous lineage (ALAL/MPAL). We discuss: - Diagnostic...

In this episode, Bernie and Anthony are joined by Myeloma Man Manni Mohyuddin, MD to discuss the debate surrounding the treatment of first relapse in multiple myeloma. Should we be using CAR-T? Bispecifics? How does the...

Episode #47
โHowever much we flatter ourselves about our individual rationality, a good story, no matter how analytically deficient, lingers in the mind, resonates emotionally, and persuades more than the most dispositive facts or...

In this special video episode, Bernie and Anthony moderate a Common Sense Oncology discussion of key trials from ASH 2025! We are joined by special guest experts from across the globe to critically appraise the...

In this episode, Anthony and Bernie are joined by a panel of experts to discuss (and debate) everyone's favorite (or most feared) hematology topic - hemophagocytic lymphohistiocytosis (HLH)! Joining us on this spicy...

Anthony and Bernie are joined by special guest Jonathan Gluck , award-winning journalist and author of "An Exercise in Uncertainty: A Memoir of Illness and Hope" for a powerful conversation about living through...

In this episode, Anthony and Bernie are joined by special guest, Dr. Justin Kaner from Weill Cornell Medicine, to discuss some of the most interesting ASH abstracts in leukemia in 2025! What abstracts should change...

Anthony and Bernie discuss the PARADIGM study that was presented at the plenary session of ASH 2025 and whether results should change our practice. https://meetings-api.hematology.org/api/abstract/vmpreview/296881

In this study, Bernie and Anthony are joined by the majestic myeloma man Manni Mohyuddin to discuss key ASH abstracts in myeloma, including the results of the MajesTEC-3 study!

Episode #40
In this episode, Anthony and Bernie discuss the important role of community hematology. We discuss innovative research models, partnerships between community and academic practices, and ways to improve care for...

In this episode, Bernie and Anthony review the optimal management of febrile neutropenia! We talk about some historical data, optimal patient workup, proper selection of antibiotics, and a discussion of newer data...

Episode #37
We're back after a summer break! In this episode, Anthony and Bernie review the optimal approach to antimicrobial prophylaxis in hematology patients. How do you best choose prophylaxis for your patients? Where are we...

In this episode, Bernie and Anthony talk about some BIG changes in cytarabine dosing in AML consolidation after a recent practice changing article. Will this change your practice? Hunault, et al. NEJM. 2025...

In this episode, Bernie and Anthony are joined by the Myeloma Man Dr. Manni Mohyuddin and lymphoma expert Dr. David Russler-Germain to discuss the very recent ODAC decisions on the STARGLO (glofitamab + GemOx) and...

This is a special encore video presentation of Anthony and Bernie teaming up with the Common Sense Oncology Journal Club series to discuss the SWOG1826 and STARGLO clinical trials. Tycel Phillips, MD, and Manju Sengar...

In this episode, Bernie and Anthony are joined by 3 hematology pharmacists - James Davis, PharmD, BCOP; Victoria Nachar, PharmD, BCOP; and Justine Preedit, PharmD, BCOP - to discuss the optimal management of CRS in...

In this episode, Bernie and Anthony are joined by Dr. Charlie Foucar and Dr. Anand Patel to review the interesting and controversy-filled saga of gemtuzumab in AML? Should we be using this agent in AML? Tune in to find...

Episode #32
In this episode, Anthony and Bernie are joined by two special guests to discuss recent updates to the use of blinatumomab in both adult and pediatric acute lymphoblastic leukemia (ALL), including the results of the...

AQUILA is a constellation shaped like an eagle, and also a hotly debated myeloma trial of daratumumab in smoldering multiple myeloma. In this episode, Bernie and Anthony are joined by myeloma expert Manni Mohyuddin to...
Recent guests on WolverHeme Happy Hour. Study who booked and why before you pitch.
VP of Global Solutions Engineering, Precision Medical Care
Clinical Pharmacy Specialist, Malignant Hematology, Bay Staters for Creative Well-Being
UK-based GP and leading specialist in menโs fertility, Centre for Menโs Health โ Anand Patel
Associate Professor in Sustainable Environmental Management, Ohio Soybean Association
PitchCentric classifies WolverHeme Happy Hour under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ